
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX

Intrinsic Value
The intrinsic value of one
CRNX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 29.99 USD,
Crinetics Pharmaceuticals Inc
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Crinetics Pharmaceuticals Inc
CRNX looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CRNX usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Fundamental Analysis


Revenue & Expenses Breakdown
Crinetics Pharmaceuticals Inc
Balance Sheet Decomposition
Crinetics Pharmaceuticals Inc
Current Assets | 1.3B |
Cash & Short-Term Investments | 1.3B |
Receivables | 7.2m |
Other Current Assets | 9.7m |
Non-Current Assets | 70.3m |
PP&E | 55.3m |
Other Non-Current Assets | 15m |
Free Cash Flow Analysis
Crinetics Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Crinetics Pharmaceuticals Inc
Revenue
|
760k
USD
|
Operating Expenses
|
-377.5m
USD
|
Operating Income
|
-376.7m
USD
|
Other Expenses
|
48.5m
USD
|
Net Income
|
-328.3m
USD
|
CRNX Profitability Score
Profitability Due Diligence
Crinetics Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Crinetics Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
CRNX Solvency Score
Solvency Due Diligence
Crinetics Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Crinetics Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRNX Price Targets Summary
Crinetics Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
CRNX
is 75.55 USD
with a low forecast of 55.55 USD and a high forecast of 101.85 USD.
Dividends
Current shareholder yield for CRNX is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CRNX
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 29.99 USD,
Crinetics Pharmaceuticals Inc
is
hidden
.